Muutke küpsiste eelistusi

The LDN Book 4: Chronic Pain Case Studies [Pehme köide]

3.00/5 (2 hinnangut Goodreads-ist)
Edited by
  • Formaat: Paperback / softback, 264 pages, kõrgus x laius x paksus: 228x152x20 mm, kaal: 1050 g, Black and White
  • Sari: LDN Books
  • Ilmumisaeg: 06-Jun-2025
  • Kirjastus: LDN Research Trust
  • ISBN-10: 1739107063
  • ISBN-13: 9781739107062
Teised raamatud teemal:
The LDN Book 4: Chronic Pain Case StudiesSuurem pilt
  • Formaat: Paperback / softback, 264 pages, kõrgus x laius x paksus: 228x152x20 mm, kaal: 1050 g, Black and White
  • Sari: LDN Books
  • Ilmumisaeg: 06-Jun-2025
  • Kirjastus: LDN Research Trust
  • ISBN-10: 1739107063
  • ISBN-13: 9781739107062
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9781739107062.html
Real Stories. Real Hope. Real Impact.

LDN Book 4 is the most comprehensive collection of real-world case studies yet, spotlighting the transformative effects of Low Dose Naltrexone (LDN) in the lives of people living with chronic pain and complex conditions.

From autoimmune and inflammatory diseases to neurological disorders, mental health challenges, and Ehlers-Danlos syndrome, this book brings together deeply personal stories from patients and practitioners who have witnessed firsthand the power of LDN.

With chapters also exploring chronic pain, endocrine conditions, and LDNs growing role in psychotherapy support, this collection presents a compassionate, balanced view of how this low-cost, low-risk treatment is changing lives around the world.

Compiled by Linda Elsegood, founder of the LDN Research Trust, and featuring contributions from international experts, LDN Book 4 is a vital, uplifting resource for patients, caregivers, and health professionals alike.

There is hope on every page.

Muu info

Awareness dates for your diary that relate to this new book:

World Hormone Day: April 24 2025

Mental Health Awareness Week (UK): 12 - 18 May 2025

Mental Health Awareness Month (US): May 2025

Ehlers-Danlos Syndromes (EDS) Awareness Month: May 2025

LDN Awareness Week: 17 - 23 June 2025

Chronic Pain Awareness Month - September 2025
To Follow
Linda Elsegood is the founder of the LDN Research Trust, a UK-registered nonprofit charity dedicated to raising awareness and providing education on Low Dose Naltrexone (LDN) for a wide range of chronic and autoimmune conditions.

Linda discovered LDN following her own diagnosis of secondary progressive multiple sclerosis. After experiencing years of debilitating relapses and being told there were no further treatment options, she began to explore alternative approaches. Her personal success with LDN led her to launch the LDN Research Trust in 2004 to help others access information, support, and guidance.

Run entirely by volunteers and supported solely through donations, the charity has become a global hub for both patients and medical professionals. Its website offers up-to-date resources, including prescriber and pharmacist directories, guides, research updates, and access to LDN-focused clinical trials.

Linda also hosts the LDN Radio Show, available on all major podcast platforms, and has produced six widely viewed documentaries highlighting the life-changing potential of LDN.